In SSc, abnormal activation of TGF-β is a signature of the disease, leading to excessive stimulation of fibroblasts and increased production of extracellular matrix components, causing the characteristic tissue fibrosis in the skin and internal organs [193]. Here, TGFB1 is linked to systemic sclerosis.